W, L., J, G., P, H., Y, F., H, C., P, M., & J, F. (2021). An integrated outsourcing practice of nonclinical LC-MS bioanalysis and toxicokinetics at Novartis small molecule drug development. Bioanalysis, 13(12), 1001. https://doi.org/10.4155/bio-2021-0072
Chicago Style (17th ed.) CitationW, Li, Glick J, Hatsis P, Fu Y, Chin H, Moench P, and Flarakos J. "An Integrated Outsourcing Practice of Nonclinical LC-MS Bioanalysis and Toxicokinetics at Novartis Small Molecule Drug Development." Bioanalysis 13, no. 12 (2021): 1001. https://doi.org/10.4155/bio-2021-0072.
MLA (9th ed.) CitationW, Li, et al. "An Integrated Outsourcing Practice of Nonclinical LC-MS Bioanalysis and Toxicokinetics at Novartis Small Molecule Drug Development." Bioanalysis, vol. 13, no. 12, 2021, p. 1001, https://doi.org/10.4155/bio-2021-0072.